Valeant Pharmaceuticals is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt and boost its stock price.» Read More
Check out which companies are making headlines after the bell Thursday:
Cramer makes the call on viewers' favorite stocks.
A spate of recent deals could be just the boost of confidence they need.
Click here for 4 potential winners and 5 possible losers if the euro falls a whole lot more!
Nearly 2.0 billion shares and $31 billion traded yesterday in CNBC's Million Dollar Portfolio Challenge. Here are the bets being made today...
The global economic boom has seen a surge in demand for raw materials, especially in countries like China and Indian. This demand has driven prices of commodities to unprecedented levels with the price of basic metals like lead and copper hitting the roof. This week's A Fund Affair looks at a fund that invests in the just the basics.
Eye-care company Bausch & Lomb, still dealing with widespread product recalls that have hurt its sales and delayed financial reports, said it agreed to be acquired by private equity firm Warburg Pincus for about $3.67 billion.
Well--the first weekly winner has been declared--Nancy Beaumont and she will be removed from the leaderboard. So how are the others doing? Here's a look from yesterday's action. Scott Wrynn maintains the top spot in the leaderboard for the second day in a row with his...